Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Jury says Johnson & Johnson owes $40 million to 2 cancer patients who used talcum powders - 26 Pet Sitting Administrations for Your Cherished Pets
- 3Opening Potential: Self-awareness and Long lasting Learning
- 4It's been 20 years since MTV's golden couple split. These producers saw it all unravel.
- 5Vote in favor of Your Number one Cake Type
- Spotify Wrapped and Apple Music Replay are here: Top songs, albums and artists of 2025
- I watched the buzzy new AI documentary — and left feeling both hopeful and terrified
- Russia earning billions from Hormuz blockade, German trade body says
- Israel Police arrest twenty-one as anti-war protests grow despite broad support for Iran war
- Manual for Big name Work out schedules
- Tesla plans to expand production at German car plant
- German Court Rejects Bid To Force BMW and Mercedes-Benz To Stop Selling New Combustion-Engine Cars After 2030
- Netflix's Eddie Murphy documentary explains 'Saturday Night Live' beef: 'That's why I didn't go back for years'
- Significant Elements to Consider Prior to Applying for a Mastercard: 6 Vital Contemplations
